Get To Know Alnylam - The Leader In Rnai Therapeutics

Get to Know Alnylam - The Leader in RNAi Therapeutics

Alnylam Pharmaceuticals

What is an RNAi Therapeutic?

Alnylam Pharmaceuticals

RNAi Therapeutics - How this New Class of Medicines Works

Alnylam Pharmaceuticals

RNAi Therapeutics - How this New Class of Medicines Works

Alnylam Pharmaceuticals

How do RNAi Therapeutics Treat Disease?

Alnylam Pharmaceuticals

What is RNAi and How Do RNAi-based Medicines Work?

Alnylam Pharmaceuticals

Silencing Disease: Shifting Treatment Paradigms with RNAi Therapeutics ft. Alnylam’s Dr. Kirk Brown

Alnylam Pharma and the Science of RNAi

Silencing Disease: Shifting Treatment Paradigms with RNAi Therapeutics ft. Alnylam’s Dr. Kirk Brown

Alnylam's New RNAi Therapy

RNAi Explained

Rare Disease Report

Alnylam Overview and it's Focus on RNA Interference

Founder Stories: John Maraganore, CEO of Alnylam pioneering RNAi therapeutics

Alnylam Pharmaceuticals CMO, Dr. Akshay Vaishnaw, Explains RNAi

From Possibility to Patients: The Scientific Odyssey - The RNAi Boom

Alnylam Pharmaceuticals

How Can Unwanted Proteins Cause or Contribute to Disease?

Alnylam Pharmaceuticals

First Approved Treatment using RNAi – Alnylam Pharmaceuticals’ and BIO Chair John Maraganore

Biotechnology Innovation Organization